-
Apixaban Versus Aspirin in Subclinical Atrial Fibrillation (SCAF): Major Bleeding Findings from Latest ARTESiA Sub-analysis
17 Nov 2025 07:21 GMT
… Journal of American Medical Association (JAMA) Cardiology … randomized clinical trial previously established that apixaban reduced … including nonsteroidal anti-inflammatory drug (NSAID) use, cancer … inform individualized antithrombotic treatment plans, such as …
-
Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome
17 Nov 2025 06:59 GMT
… trial programme includes two other phase 3 trials, … president, drug development, immunology and cardiovascular medicines, Bristol Myers Squibb … advances in antithrombotic treatment, anticoagulation therapy is … of milvexian versus apixaban in participants with …
-
Update on Phase 3 Librexia ACS Trial
14 Nov 2025 13:37 GMT
… trial program includes two other Phase 3 trials … president, drug development, Immunology and Cardiovascular Medicines, Bristol Myers Squibb … advances in antithrombotic treatment, anticoagulation therapy … and commercialization of pharmaceutical products. All …
-
Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats
10 Nov 2025 16:20 GMT
… apixaban), Ibrance (palbociclib), and Xtandi (enzalutamide) over the coming years. Blood … channels. Pfizer originally agreed to buy the biotech for … accusing the Danish drugmaker and Metsera of … you deserve! The Pharmaceutical Technology Excellence Awards …
-
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
08 Nov 2025 15:46 GMT
… Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed positive Phase 2 trial … profiles. In these trials, both antibodies demonstrated …
REGN7508Cat
REGN9933A2
enoxaparin
apixaban
Patients with VTE … into medicine has led to numerous approved treatments …
-
Dear Doctor: Can blood thinners contribute to patient’s low platelet count?
07 Nov 2025 15:49 GMT
… treatment remains effective. There are two different classes of medications … apixaban (Eliquis). These directly block the body’s ability to make blood … drugs nor DOACs actually thin the blood. Too-thick blood … worrisome range, his doctors aren’t concerned …
-
TO YOUR GOOD HEALTH: 2 types of meds can help lessen blood clots
07 Nov 2025 08:36 GMT
… treatment remains effective. There are two different classes of medications … apixaban (Eliquis). These directly block the body’s ability to make blood … drugs nor DOACs actually thin the blood. Too-thick blood … worrisome range, his doctors aren’t concerned …
-
Active Pharmaceutical Ingredients CDMO Market to Worth USD 260.98 Billion by 2034
05 Nov 2025 17:00 GMT
… customised medicine, gene editing, and advanced vaccines. … FDA product-specific guidances for complex generics, particularly Amikacin Sulfate and Apixaban … HPAPIs) and biotech. Eventually, the … active pharmaceutical ingredients (APIs) for cancer drugs.
…
-
AHA 2025: Mandrola’s Four Trials To Look For
04 Nov 2025 15:36 GMT
… trial, which compares direct oral anticoagulant (DOAC) monotherapy (apixaban … nonsignificant primary prevention aspirin trials (ASCEND, ARRIVE and … endpoint — on top of statin use.
At AHA we … a conservative approach to medical practice. He participates …
-
5 Medications That May Interact With Omega-3 Supplements
01 Nov 2025 18:48 GMT
… oral anticoagulants such as Eliquis (apixaban) and Xarelto (rivaroxaban)
Antiplatelets … your blood clots.
2. Blood Pressure Drugs
In addition to blood thinners, … medication to prevent hypoglycemia (low blood sugar).
4. Nonsteroidal Anti-Inflammatory Drugs …
About
© 1995-2025